Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
4820 Emperor Blvd., Durham, NC, 27703, US
Clinical research is undergoing a major transformation as patient-centricity becomes the foundation of trial design and execution.
Released By IQVIA
The pharmaceutical and biotech landscape is undergoing rapid transformation, driven by decentralized clinical trials, advanced analytics, and a renewed focus on patient-centricity.
How connected devices are making trials more patient centric.
Insights and best practices for a new era of drug development
Jones will focus on accelerating GENMOR-AI, the company's proprietary platform for identifying genetic modifiers of disease using AI.
By: Charlie Sternberg
Global partnerships will help customers improve clinical and commercial efficiency and effectiveness.
By: Rachel Klemovitch
Addressing increasing complexity, cost of drug development, and navigating regulatory compliance.
By: Kristin Brooks
How can early decisions in cell and gene therapy clinical development impact downstream progress toward commercialization and patient access?
By: Dr. Diego Correa, Erin Finot
Spreen previously served as Chief Commercial Officer at IQVIA.
Isaac Batley offers 35 years of leadership experience working in healthcare communications within the pharmaceutical sector.
Modi brings extensive experience from the life sciences industry, having held leadership roles at both IQVIA and GSK.
Stafford offers more than 35 years of industry experience.
Ratliff succeeds Ludo Reynders, who will be retiring and will become an advisor to the company and remain a board member.
Research & Development Solutions revenue up 7% to $2.1 billion.
Regulatory agencies are adapting to the digital age by implementing processes and documentation enabled by modern technology.
By: Rama Mohan
Brown is currently UBC’s chief operating officer with more than 20 years of senior management experience.
Robbie has more than 25 years of experience with biomarker assay technologies, including 20 years of experience in scientific leadership positions.
New workflow tool delivers enhanced AI-driven customer engagement.
Total baseline value for Emergent is approximately $90 million USD, further expanding the collaboration between the companies, which began in February 2021.
Released By Emergent Bioservices
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
